| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/16/2009 | US7547768 Anti-TAT 113 antibodies |
| 06/16/2009 | US7547767 Growth arrest specific gene 6 peptides, antibodies, compositions, methods and uses |
| 06/16/2009 | US7547766 Anti-tango294 antibodies and uses thereof |
| 06/16/2009 | US7547763 Sequences of an Ih ion channel and use thereof |
| 06/16/2009 | US7547682 Useful as a candidate for a vaccine against ticks, particularly Ornithodoros moubata, tick-borne infections such as rickettsiosis, filariasis, Q fever, African recurrent fever, or viral encephalitis |
| 06/16/2009 | US7547662 Target recognizing binding agents |
| 06/16/2009 | US7547544 Hybridoma cell line for production of immunoglobulins specific to g protein coupled receptor for use in prevention and treatment of cell proliferative disorders |
| 06/16/2009 | US7547518 Method of screening endothelial cells for angiogenic capability |
| 06/16/2009 | US7547507 Methods for the diagnosis of tumors |
| 06/16/2009 | US7547439 Elicit immune response from human lymphocytes when complexed with a major histocompatibility complex molecule type HLA-A2; polypeptide |
| 06/16/2009 | US7547438 CD40-binding activating antibodies |
| 06/16/2009 | US7547437 Kidney or liver fibrosis; using antagonist against the mitogenic vascular endothelial growth factors (zvegf3), such as a monoclonal antibody against zvegf3, receptor binding variants, or antisense agents; antagonist of zvegf3 inhibits cell proliferation; humanized, single-chain antibody |
| 06/16/2009 | CA2399910C Mammalian secreted group iii phospholipase a2 |
| 06/16/2009 | CA2282727C Cell surface molecule mediating cell adhesion and signal transmission |
| 06/16/2009 | CA2266439C Neutrokine .alpha. |
| 06/16/2009 | CA2255101C Immunoreactive regions of glycoprotein gpii of varicella zoster virus (vzv) |
| 06/16/2009 | CA2158322C Immunoconjugate comprising an anti-egf receptor antibody and interleukin-8 |
| 06/11/2009 | WO2009073805A2 Aglycosylated therapeutic antibodies and therapeutic antibody-encoding nucleotide sequences |
| 06/11/2009 | WO2009073631A2 Antibodies to the pcrv antigen of pseudomonas aeruginosa |
| 06/11/2009 | WO2009073160A1 Anti-vegf antibodies |
| 06/11/2009 | WO2009073115A1 Combination vegfr2 therapy with mtor inhibitors |
| 06/11/2009 | WO2009072660A1 Method for production of antibody |
| 06/11/2009 | WO2009072628A1 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
| 06/11/2009 | WO2009072604A1 Anti-nr10 antibody and use thereof |
| 06/11/2009 | WO2009072598A1 Therapeutic agent for pruritus |
| 06/11/2009 | WO2009072588A1 Monoclonal antibody responsive to mouse polymeric immunoglobulin receptor |
| 06/11/2009 | WO2009071892A2 Method for the detection of dead and dying cells |
| 06/11/2009 | WO2009071860A2 G immunoglobulin used against anthrax toxins |
| 06/11/2009 | WO2009071696A2 Humanized antibody molecules specific for il-31 |
| 06/11/2009 | WO2009071659A1 Trophic factor for the treatment of retinal degenerative diseases |
| 06/11/2009 | WO2009070957A1 Inhibitor of the interaction between blys and ngr and use thereof |
| 06/11/2009 | WO2009070844A1 Method of inhibition of leukemic stem cells |
| 06/11/2009 | WO2009054708A3 Antibody therapy for highly pathogenic avian influenza virus |
| 06/11/2009 | WO2009041832A3 Vaccines and vaccine components for inhibition of microbial cells |
| 06/11/2009 | WO2009030978A3 Conformers of bacterial adhesins |
| 06/11/2009 | WO2009027752A3 Process for producing hepcidin |
| 06/11/2009 | WO2009012181A3 Method of identifying diagnostic reagents |
| 06/11/2009 | WO2008149147A3 Polypeptides, antibody variable domains and antagonists |
| 06/11/2009 | WO2008149146A3 Polypeptides, antibody variable domains and antagonists |
| 06/11/2009 | WO2007028106A3 Host cell lines for production of antibody constant region with enhanced effector function |
| 06/11/2009 | WO2004013092A3 Beta-alanine n-methyltransferase |
| 06/11/2009 | WO2002099058A3 KCNMAs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 06/11/2009 | US20090151025 Indeterminate Gametophyte 1 (ig1), Mutations of ig1, Orthologs of ig1, and Uses Thereof |
| 06/11/2009 | US20090151019 Late blight resistance gene from wild potato |
| 06/11/2009 | US20090151013 Modified ES cells and ES cell-specific genes |
| 06/11/2009 | US20090149637 Human antibodies derived from immunized xenomice |
| 06/11/2009 | US20090149636 Cytokine protein family |
| 06/11/2009 | US20090149635 Antibodies to human zcytor17 ligand |
| 06/11/2009 | US20090149410 Methods, compositions, and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 06/11/2009 | US20090149393 Novel Proteins Within The Type E Botulinum Neurotoxin Complex |
| 06/11/2009 | US20090149379 Novel use of cytokine inhibitors |
| 06/11/2009 | US20090149374 Neuropeptides |
| 06/11/2009 | US20090149331 Methods and compositions for polypeptide engineering |
| 06/11/2009 | US20090148948 Nucleic acids encoding a g-protein coupled receptor involved in taste transduction |
| 06/11/2009 | US20090148942 Humanized anti-cd70 binding agents and uses thereof |
| 06/11/2009 | US20090148940 Novel fluorescent proteins from aequorea coerulscens and methods for using same |
| 06/11/2009 | US20090148939 Novel fluorescent proteins from aequorea coerulscens and methods for using same |
| 06/11/2009 | US20090148905 Antigen-binding constructs |
| 06/11/2009 | US20090148904 Production of cytotoxic antibody-toxin fusion in eukaryotic algae |
| 06/11/2009 | US20090148878 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/11/2009 | US20090148866 Antibodies and Improved Test Sample Handling Methods for Use in Assays for Myeloperoxidase |
| 06/11/2009 | US20090148864 Methods and compositions for the detection of cervical disease |
| 06/11/2009 | US20090148854 Can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 184P1E2 can be used in active or passive immunization |
| 06/11/2009 | US20090148539 Methods, compositions, and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 06/11/2009 | US20090148513 Compositions and methods for crystallizing antibodies |
| 06/11/2009 | US20090148510 GPCR crystalization method using an antibody |
| 06/11/2009 | US20090148507 Chimeric polypeptides containing chemokine domains |
| 06/11/2009 | US20090148465 Mutants of the p4 protein of nontypable haemophilus influenzae with reduced enzymatic activity |
| 06/11/2009 | US20090148461 Anti fgf23 antibody and a pharmaceutical composition comprising the same |
| 06/11/2009 | US20090148460 Exosome ligands, their preparation and uses |
| 06/11/2009 | US20090148459 Prevention or Treatment of Cancer Using Integrin alphavbeta3 Antagonists in Combination with Other Agents |
| 06/11/2009 | US20090148457 Hepatocyte growth factor receptor antagonists and uses thereof |
| 06/11/2009 | US20090148456 Canine rankl and methods for preparing and using the same |
| 06/11/2009 | US20090148455 Anti-RANTES antibodies and methods of use thereof |
| 06/11/2009 | US20090148454 Peptide Domain Required For Interaction Between The Envelope of a Virus Pertaining to The Herv-W Interference Group and an Hasct Receptor |
| 06/11/2009 | US20090148453 Monoclonal antibodies against HMGB1 |
| 06/11/2009 | US20090148451 Therapeutic anti-cytomegalovirus compounds |
| 06/11/2009 | US20090148450 ATF4 As A Therapeutic Target In Alzheimers Disease And Other Neurological Disorders |
| 06/11/2009 | US20090148449 Antibodies against cd38 for treatment of multiple myeloma |
| 06/11/2009 | US20090148447 Binding Peptides Having a C-terminally Disposed Specific Binding Domain |
| 06/11/2009 | US20090148444 Pharmaceutical composition for treating immune diseases |
| 06/11/2009 | US20090148443 Humanized antibodies and compositions for binding sphingosine-1-phosphate |
| 06/11/2009 | US20090148441 Anti-Cancer Antibodies With Reduced Complement Fixation |
| 06/11/2009 | US20090148440 Antibodies against interleukin-22 binding protein and its uses for the treatment of metabolic disorders |
| 06/11/2009 | US20090148439 by use of a polypeptide (CD27L); in particular kidney cancer; monitoring the effectiveness of epithelial-derived cancer therapy |
| 06/11/2009 | US20090148438 Binding Moieties Based on Shark Ignar Domains |
| 06/11/2009 | US20090148437 Polypeptides, antibody variable domains & antagonists |
| 06/11/2009 | US20090148436 Antibody to gdf8 and uses thereof |
| 06/11/2009 | US20090148434 Antibody Compositions and Methods |
| 06/11/2009 | US20090148402 Therapy of non-malignant diseases or disorders with anti-erbb2 antibodies |
| 06/11/2009 | US20090148383 Anticoagulation Agent and Uses Thereof |
| 06/11/2009 | CA2708532A1 Anti-nr10 antibody and use thereof |
| 06/11/2009 | CA2708251A1 Humanized antibody molecules specific for il-31 |
| 06/11/2009 | CA2708065A1 Therapeutic agent for pruritus |
| 06/11/2009 | CA2707689A1 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
| 06/11/2009 | CA2707201A1 G immunoglobulin used against anthrax toxins |
| 06/11/2009 | CA2706732A1 Antibodies to the pcrv antigen of pseudomonas aeruginosa |
| 06/11/2009 | CA2706337A1 Method of inhibition of leukemic stem cells |
| 06/11/2009 | CA2703790A1 Anti-vegf antibodies |
| 06/10/2009 | EP2067863A2 Methods and compositions for diseases associated with amyloidosis |